Category: Parkinson's Disease: Genetics
Objective: To improve the prediction of Parkinson’s disease (PD) by examining aggregate profiles of gene expression in the form of transcriptional risk scores (TRS).
Background: Although genome-wide association studies (GWAS) capture substantial variant-based heritability for PD, polygenic score (PGS) prediction remains limited. PGS prediction has been successfully improved for outcomes such as ADHD by integrating multiple PGS in the same model (multi-PGS). TRS – calculated as the weighted sum of an individual’s observed gene expression – offers a complementary approach to understanding the biological contributions to PD risk and improving predictive models. Our previous work (forthcoming) has demonstrated for the first time that TRS can identify novel within- and cross-trait associations between gene expression profiles, PD and its phenotypes not identified using PGS alone. However, the multi-score modelling strategy has not yet been applied to TRS nor within PD.
Method: We conduct transcriptome-wide association analysis (TWAS) across multiple phenotypes, including neurodegenerative diseases, psychiatric disorders, cardiovascular outcomes, metabolic traits, and cognitive performance measures. TWAS-derived expression weights were applied to RNA-seq data from AMP-PD (https://www.amp-pd.org) (Ncases = 2,071; Ncontrols = 1,465). After univariate analysis, a multi-TRS model for PD case/control status combining significant TRS from phenotypes will be trained using logistic regression with elastic net regularisation.
Results: In preliminary univariate analyses we find several novel associations, including that depression, schizophrenia and Alzheimer’s disease TRS predict between 1.5-2% of the variance in PD status (p_FDR ≤ 0.05). We expect combined multi-TRS models to significantly improve the prediction of PD status.
Conclusion: This is the biggest TRS study on PD and represents the first application of a multi-TRS approach to PD prediction. By integrating TRS from multiple phenotypes, this work aims to provide novel biological insights into PD and improve disease prediction.
To cite this abstract in AMA style:
L. Gilchrist, O. Pain, A. Noyce, K. Brolin, M. Periñán, P. Proitsi. A Multi-Transcriptional Risk Score Approach to Parkinson’s Disease Prediction [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-multi-transcriptional-risk-score-approach-to-parkinsons-disease-prediction/. Accessed October 5, 2025.« Back to 2025 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/a-multi-transcriptional-risk-score-approach-to-parkinsons-disease-prediction/